|
Report Date : |
27.12.2013 |
IDENTIFICATION DETAILS
|
Name : |
ELEKTA LTD. |
|
|
|
|
Formerly Known As : |
Elekta Oncology
Systems Ltd |
|
|
|
|
Registered Office : |
Linac House, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
30.04.2013 |
|
|
|
|
Date of Incorporation : |
02.09.1996 |
|
|
|
|
Com. Reg. No.: |
03244454 |
|
|
|
|
Legal Form : |
Private
Subsidiary |
|
|
|
|
Line of Business : |
Engaged in
manufacturing and sale of medical capital equipment and associated software
specifically for the treatment of cancer. |
|
|
|
|
No. of Employees : |
595 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30th, 2013
|
Country Name |
Previous Rating (30.06.2013) |
Current Rating (30.09.2013) |
|
United Kingdom |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
United Kingdom ECONOMIC OVERVIEW
The UK, a leading
trading power and financial center, is the second largest economy in Europe
after Germany. Over the past two decades, the government has greatly reduced
public ownership and contained the growth of social welfare programs.
Agriculture is intensive, highly mechanized, and efficient by European
standards, producing about 60% of food needs with less than 2% of the labor
force. The UK has large coal, natural gas, and oil resources, but its oil and
natural gas reserves are declining and the UK became a net importer of energy
in 2005. Services, particularly banking, insurance, and business services,
account by far for the largest proportion of GDP while industry continues to
decline in importance. After emerging from recession in 1992, Britain's economy
enjoyed the longest period of expansion on record during which time growth
outpaced most of Western Europe. In 2008, however, the global financial crisis
hit the economy particularly hard, due to the importance of its financial
sector. Sharply declining home prices, high consumer debt, and the global
economic slowdown compounded Britain's economic problems, pushing the economy
into recession in the latter half of 2008 and prompting the then BROWN (Labour)
government to implement a number of measures to stimulate the economy and
stabilize the financial markets; these include nationalizing parts of the
banking system, temporarily cutting taxes, suspending public sector borrowing
rules, and moving forward public spending on capital projects. Facing
burgeoning public deficits and debt levels, in 2010 the CAMERON-led coalition
government (between Conservatives and Liberal Democrats) initiated a five-year
austerity program, which aimed to lower London's budget deficit from over 10%
of GDP in 2010 to nearly 1% by 2015. In November 2011, Chancellor of the
Exchequer George OSBORNE announced additional austerity measures through 2017
because of slower-than-expected economic growth and the impact of the euro-zone
debt crisis. The CAMERON government raised the value added tax from 17.5% to
20% in 2011. It has pledged to reduce the corporation tax rate to 21% by 2014.
The Bank of England (BoE) implemented an asset purchase program of up to £375
billion (approximately $605 billion) as of December 2012. During times of
economic crisis, the BoE coordinates interest rate moves with the European
Central Bank, but Britain remains outside the European Economic and Monetary
Union (EMU). In 2012, weak consumer spending and subdued business investment
weighed on the economy. GDP fell 0.1%, and the budget deficit remained
stubbornly high at 7.7% of GDP. Public debt continued to increase.
|
Source : CIA |
Elekta Ltd.
Linac House
Fleming Way
Crawley, RH10 9RR
United Kingdom
Tel: 01293544422
Fax: 01293654321
Web: www.elekta.com
Employees: 595
Company Type: Private
Subsidiary
Corporate Family: 55 Companies
Ultimate Parent: Elekta publ AB
Quoted Status: Non-quoted
Company
Incorporation
Date: 02-Sep-1996
Auditor: Deloitte
LLP
Financials in: USD (Millions)
Fiscal Year End: 30-Apr-2013
Reporting
Currency: British Pound Sterling
Annual Sales: 696.6 1
Net Income: 75.0
Total Assets: 545.1
Manufacture and
sale of medical capital equipment and associated software specifically for the
treatment of cancer.
Industry
Industry
Medical Equipment and Supplies
ANZSIC 2006: 2412 - Medical and Surgical Equipment
Manufacturing
ISIC Rev 4: 3250 - Manufacture of medical and
dental instruments and supplies
NACE Rev 2: 3250 - Manufacture of medical and dental
instruments and supplies
NAICS 2012:
33911 - Medical Equipment and Supplies Manufacturing
UK SIC 2007:
3250 - Manufacture of medical and dental instruments and supplies
US SIC 1987:
384 - Surgical, Medical, and Dental Instruments and Apparatus
|
Name |
Title |
|
Johan Axel Edvin Sedihn |
Chief Executive Officer Uk Legal Entity, Director |
|
Elekta Brachytherapy |
Executive Vice President |
|
Per Hakan Bergstrom |
Chief Financial Officer, Director |
|
Dee Mathieson |
Senior Vice President, Business Line Management |
|
Catherine Geraldine Regan |
Senior Legal Counsel and Company Secretary |
|
||||||||||||||||||||||
1 - Profit &
Loss Item Exchange Rate: USD 1 = GBP 0.6351951
2 - Balance Sheet
Item Exchange Rate: USD 1 = GBP 0.645416
Location
Linac House
Fleming Way
Crawley, RH10 9RR
West Sussex
County
United Kingdom
Tel: 01293544422
Fax: 01293654321
Web: www.elekta.com
Sales GBP(mil): 442.5
Assets GBP(mil): 351.8
Employees: 595
Fiscal Year End: 30-Apr-2013
Industry: Medical Equipment and
Supplies
Registered Address:
Linac House
Fleming Way
Crawley, RH10 9RR
United Kingdom
Incorporation
Date: 02-Sep-1996
Company Type: Private Subsidiary
Quoted Status: Not Quoted
Previous Name: Elekta Oncology Systems Ltd
Registered
No.(UK): 03244454
Chief Executive Officer
Uk Legal Entity, Director:
Johan Axel Edvin
Sedihn
Industry Codes
ANZSIC 2006
Codes:
2412 - Medical
and Surgical Equipment Manufacturing
ISIC Rev 4 Codes:
3250 - Manufacture
of medical and dental instruments and supplies
NACE Rev 2 Codes:
3250 - Manufacture
of medical and dental instruments and supplies
NAICS 2012 Codes:
33911 - Medical
Equipment and Supplies Manufacturing
US SIC 1987:
384 - Surgical,
Medical, and Dental Instruments and Apparatus
UK SIC 2007:
3250 - Manufacture of medical and dental
instruments and supplies
Business Description
Manufacture and sale of medical capital equipment and
associated software specifically for the treatment of cancer.
More Business
Descriptions
Medical Radiation
Treatment Equipment Mfr & Sales
Surgical &
medical instruments
Medical Equipment
Manufacture